As we previously discussed (here and here), the biotech mergers and acquisitions market currently faces significant headwinds. These challenges include frozen capital markets, regulatory uncertainty at the Food and Drug...more
6/10/2025
/ Acquisitions ,
Biotechnology ,
Capital Markets ,
Corporate Governance ,
Department of Health and Human Services (HHS) ,
Food and Drug Administration (FDA) ,
Initial Public Offering (IPO) ,
Mergers ,
Pharmaceutical Industry ,
Securities and Exchange Commission (SEC) ,
Shareholders ,
Spinoffs ,
Tax Planning ,
Tax-Free Spin-Offs
On August 7, after weeks of negotiations, the Senate voted 51-50 to pass a budget reconciliation package known as the Inflation Reduction Act (the “Bill”), introduced by Senators Joe Manchin (D‑WV) and Chuck Schumer (D‑NY) in...more
8/11/2022
/ Affordable Care Act ,
Alternative Minimum Tax ,
Carbon Capture and Sequestration ,
Clean Energy ,
Corporate Taxes ,
Energy Tax Incentives ,
Excise Tax ,
International Trade Commission (ITC) ,
IRS ,
Manufacturing Facilities ,
Offshore Wind ,
Tax Credits